-
June 29, 2010
On June 28, the U.S. Food and Drug Administration approved the first generic version of Effexor XR capsules (venlafaxine hydrochloride)...
-
June 25, 2010
The U.S. Food and Drug Administration today announced approval of the first rapid blood test for antibodies to the hepatitis...
-
June 21, 2010
Pfizer Inc. today announced the voluntary withdrawal from the U.S. market of the drug Mylotarg (gemtuzumab ozogamicin) for patients with...
-
June 17, 2010
Approval expands use in treatment of rare type of leukemia
The U.S. Food and Drug Administration today approved a new indication...
-
June 17, 2010
The U.S. Food and Drug Administration today approved Jevtana (cabazitaxel), a chemotherapy drug used in combination with the steroid prednisone...
-
June 16, 2010
The May 2010 Drug Safety Labeling Changes posting includes 23 products with safety labeling changes to the following sections: BOXED...
-
June 15, 2010
New website will contain safety reports on recently approved drugs, biologics
The U.S. Food and Drug Administration today unveiled a new...
-
June 10, 2010
January 9-12, 2011 in Washington, DC ~
Clinical trial safety and postmarketing pharmacovigilance is more critical than ever in the development...
-
June 9, 2010
By Elizabeth Lopatto, June 9 (Bloomberg) — Regeneron Pharmaceuticals Inc. reported a successful study result in its new drug for...
-
June 9, 2010
January 24-25, 2011 in Arlington, VA ~ Practical Strategies for Determining Risk Thresholds, Implementing and Assessing REMS Programs.
Any risk management...
